Press release
September 3, 2026
Quince Therapeutics to Participate in September 2026 Investor Conferences
IRulya Therapeutics Inc. (IRLA)
SOUTH SAN FRANCISCO, Calif., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Quince Therapeutics, Inc. (Nasdaq: QNCX), a clinical stage biopharmaceutical company focused on the development of novel, disease modifying therapies for serious underserved diseases, today announced that senior management will